Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Lamy

Showing results (111-120 of 139) with videos related to

Pageof 14
Sort By:
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|August 4, 2009
Structural properties of lipid reconstructs and lipid composition of normotensive and hypertensive rat vascular smooth muscle cell membranesT R Oliveira, M T Lamy, U M De Paula, et al.
Leukemia|October 22, 2011
Characterization of intratumoral follicular helper T cells in follicular lymphoma: role in the survival of malignant B cellsP Amé-Thomas, J Le Priol, H Yssel, et al.
Internal Medicine Journal|August 23, 2012
Cross-sectional validation study of patient-reported outcomes in patients with paroxysmal nocturnal haemoglobinuriaI Weitz, G Meyers, T Lamy, et al.
Leukemia|November 28, 2013
Cyclophosphamide as a first-line therapy in LGL leukemiaA Moignet, Z Hasanali, R Zambello, et al.
Advances in Hematology|April 12, 2014
Results of a Prospective Study of High-Dose or Conventional Anthracycline-Cyclophosphamide Regimen Plus Radiotherapy for Localized Adult Non-Hodgkin's Primary Bone LymphomaA Schmidt-Tanguy, R Houot, S Lissandre, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1997
Is the International Prognostic Index for aggressive lymphomas useful for low-grade lymphoma patients? Applicability to stage III-IV patients. The GOELAMS Group, FranceC Foussard, B Desablens, L Sensebe, et al.
Leukemia|October 15, 2010
Follicular lymphoma cell niche: identification of a preeminent IL-4-dependent T(FH)-B cell axisC Pangault, P Amé-Thomas, P Ruminy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 8, 2005
Long-term follow-up of a randomized trial of fludarabine-mitoxantrone, compared with cyclophosphamide, doxorubicin, vindesine, prednisone (CHVP), as first-line treatment of elderly patients with advanced, low-grade non-Hodgkin's lymphoma before the era of monoclonal antibodiesC Foussard, P Colombat, H Maisonneuve, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 27, 2010
18F-fluorodeoxyglucose-positron emission tomography before, during and after treatment in mature T/NK lymphomas: a study from the GOELAMS groupX Cahu, C Bodet-Milin, E Brissot, et al.
The Review of Scientific Instruments|March 3, 2016
Charge breeder for the SPIRAL1 upgrade: Preliminary resultsL Maunoury, P Delahaye, M Dubois, et al.
Pageof 14

Showing results (111-120 of 139) with videos related to

Sort By:
Pageof 14
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|August 4, 2009
Structural properties of lipid reconstructs and lipid composition of normotensive and hypertensive rat vascular smooth muscle cell membranesT R Oliveira, M T Lamy, U M De Paula, et al.
Leukemia|October 22, 2011
Characterization of intratumoral follicular helper T cells in follicular lymphoma: role in the survival of malignant B cellsP Amé-Thomas, J Le Priol, H Yssel, et al.
Internal Medicine Journal|August 23, 2012
Cross-sectional validation study of patient-reported outcomes in patients with paroxysmal nocturnal haemoglobinuriaI Weitz, G Meyers, T Lamy, et al.
Leukemia|November 28, 2013
Cyclophosphamide as a first-line therapy in LGL leukemiaA Moignet, Z Hasanali, R Zambello, et al.
Advances in Hematology|April 12, 2014
Results of a Prospective Study of High-Dose or Conventional Anthracycline-Cyclophosphamide Regimen Plus Radiotherapy for Localized Adult Non-Hodgkin's Primary Bone LymphomaA Schmidt-Tanguy, R Houot, S Lissandre, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1997
Is the International Prognostic Index for aggressive lymphomas useful for low-grade lymphoma patients? Applicability to stage III-IV patients. The GOELAMS Group, FranceC Foussard, B Desablens, L Sensebe, et al.
Leukemia|October 15, 2010
Follicular lymphoma cell niche: identification of a preeminent IL-4-dependent T(FH)-B cell axisC Pangault, P Amé-Thomas, P Ruminy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 8, 2005
Long-term follow-up of a randomized trial of fludarabine-mitoxantrone, compared with cyclophosphamide, doxorubicin, vindesine, prednisone (CHVP), as first-line treatment of elderly patients with advanced, low-grade non-Hodgkin's lymphoma before the era of monoclonal antibodiesC Foussard, P Colombat, H Maisonneuve, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 27, 2010
18F-fluorodeoxyglucose-positron emission tomography before, during and after treatment in mature T/NK lymphomas: a study from the GOELAMS groupX Cahu, C Bodet-Milin, E Brissot, et al.
The Review of Scientific Instruments|March 3, 2016
Charge breeder for the SPIRAL1 upgrade: Preliminary resultsL Maunoury, P Delahaye, M Dubois, et al.
Pageof 14